DR Horton Share Price BOERSE MUENCHEN

Equities

HO2

US23331A1097

Homebuilding

Real-time BOERSE MUENCHEN 20:46:39 22/05/2024 BST 5-day change 1st Jan Change
133.8 EUR -2.68% Intraday chart for DR Horton -7.11% -2.22%

Financials

Sales 2024 * 36.92B 34.11B 2,902B Sales 2025 * 39.41B 36.4B 3,097B Capitalization 47.62B 43.98B 3,742B
Net income 2024 * 4.72B 4.36B 371B Net income 2025 * 5B 4.62B 393B EV / Sales 2024 * 1.33 x
Net Debt 2024 * 1.36B 1.26B 107B Net Debt 2025 * 1.02B 943M 80.2B EV / Sales 2025 * 1.23 x
P/E ratio 2024 *
10.2 x
P/E ratio 2025 *
9.3 x
Employees -
Yield 2024 *
0.83%
Yield 2025 *
0.89%
Free-Float 73.76%
More Fundamentals * Assessed data
Dynamic Chart
1 week-7.11%
Current month+0.09%
1 month-0.73%
3 months-0.55%
6 months+14.72%
Current year-2.22%
More quotes
1 week
133.50
Extreme 133.5
145.72
1 month
130.58
Extreme 130.58
145.72
3 years
57.21
Extreme 57.21
152.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 31/12/98
Chairman 68 31/12/87
Director of Finance/CFO 58 31/12/97
Members of the board TitleAgeSince
Director of Finance/CFO 58 31/12/97
Director/Board Member 78 22/01/14
Director/Board Member 73 19/04/21
More insiders
Date Price Change
22/05/24 133.8 -2.68%
21/05/24 137.4 +0.61%
20/05/24 136.6 -1.73%
17/05/24 139 -0.53%
16/05/24 139.7 -2.96%

Real-time BOERSE MUENCHEN, May 22, 2024 at 08:46 pm

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
144.6 USD
Average target price
169.8 USD
Spread / Average Target
+17.44%
Consensus